Why the study?
Does EuroScore 2 accurately predict 30-day mortality compared to other risk scores in patients undergoing transapical aortic valve implantation or conventional aortic valve replacement?
Does EuroScore 2 accurately predict 30-day mortality compared to other risk scores in patients undergoing transapical aortic valve implantation or conventional aortic valve replacement?
EuroScore 2 provides a more accurate estimation of 30-day mortality than the older logistic EuroScore in patients undergoing TA-TAVI or cAVR, though new cut-offs are needed for individual patient triage.
No takes yet. Share an insight, caveat, or question.
EuroScore 2 better matches observed 30-day mortality than logistic EuroScore in TA-TAVI and cAVR; leaves open optimal cutoffs for patient selection.
Goetzenich et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: